Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells.
about
Controlled actuation of therapeutic nanoparticles: an update on recent progressConstruction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy.LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study.Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.Functionalized protein nanocages as a platform of targeted therapy and immunodetection.Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancerProtein cage nanostructure as drug delivery system: magnifying glass on apoferritin.Serum ferritin and primary lung cancer.In Vitro Permeation of FITC-loaded Ferritins Across a Rat Blood-brain Barrier: a Model to Study the Delivery of Nanoformulated Molecules.In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy.Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors
P2860
Q28077645-960CC058-7210-4AC7-AF0D-4FEB81A624FDQ31132658-F09A6DAA-5B7C-42E1-8A16-F62B885BE63EQ36156185-79731C5F-7203-4BF0-AE93-CB12F7297443Q37702718-F47530B7-02E7-48F6-B5C4-B513911B4584Q38664186-BC641A4D-AE34-4936-8F31-367DB321FB75Q38774730-925D9A0E-0F11-406E-9218-A2334C207B14Q39076542-B2AC9B2C-8BE2-4206-988A-EACE3DA867D4Q41183225-969D63D7-623E-4387-8EE0-C710B688E4F3Q41309782-67037691-4F48-4C8E-A1AC-915B02AD1C86Q45858764-7B885236-42ED-45F3-89B1-487A37F7B247Q47094158-94E57E9B-A834-4010-8063-10B4641671B4Q48537583-DC0B231C-C1D8-4132-9B3C-B75B3E6F7AFEQ54236664-E0C3C331-5E08-451F-9947-6ED7BC1FB6E8Q55024462-D7BEDC83-B298-49C6-8462-F0093795AD94Q58134759-4159969A-D140-47F3-8770-F6A0F7EEF865
P2860
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Protein nanocages for self-tri ...... otherapeutics in Cancer Cells.
@en
type
label
Protein nanocages for self-tri ...... otherapeutics in Cancer Cells.
@en
prefLabel
Protein nanocages for self-tri ...... otherapeutics in Cancer Cells.
@en
P2093
P50
P1476
Protein nanocages for self-tri ...... otherapeutics in Cancer Cells.
@en
P2093
Davide Prosperi
Elisabetta Galbiati
Maria A Rizzuto
Michela Bellini
Silvia Sommaruga
P304
P356
10.1016/J.JCONREL.2014.10.002
P407
P577
2014-10-13T00:00:00Z